Successful multimodality treatment for advanced hepatocellular carcinoma with tumor thrombosis of the main portal trunk: a case study

Clin J Gastroenterol. 2021 Oct;14(5):1517-1524. doi: 10.1007/s12328-021-01481-9. Epub 2021 Jul 21.

Abstract

The overall survival of patients with advanced hepatocellular carcinoma with tumor thrombosis of the main trunk or bilobar branches of the portal vein is extremely poor. Moreover, there is no standard treatment established for the condition. Herein, we present the case of a 65-year-old man who were treated the patient with hepatic arterial infusion chemotherapy, radiation therapy for tumor thrombosis, portal vein stent placement, lenvatinib administration, and renal venous shunt embolization. A complete response was observed according to mRECIST and the patient has been alive for 14 months since treatment initiation with no tumor recurrence.

Keywords: Hepatic arterial infusion chemotherapy; Hepatocellular carcinoma; Lenvatinib; Portal vein tumor thrombosis; Radiation therapy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Hepatocellular* / drug therapy
  • Carcinoma, Hepatocellular* / therapy
  • Humans
  • Infusions, Intra-Arterial
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / therapy
  • Male
  • Neoplasm Recurrence, Local
  • Portal Vein
  • Thrombosis* / etiology
  • Thrombosis* / therapy